Fundamental Analysis of DANIMER SCIENTIFIC INC(NYSE:DNMR) stock

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to DNMR. DNMR was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of DNMR have multiple concerns. DNMR is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

DNMR had negative earnings in the past year.

In the past year DNMR has reported a negative cash flow from operations.

In the past 5 years DNMR always reported negative net income.

DNMR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -17.27%, DNMR is not doing good in the industry: 89.16% of the companies in the same industry are doing better.

The Return On Equity of DNMR (-52.55%) is worse than 86.75% of its industry peers.

		Industry Rank	Sector Rank
ROA	-17.27%
ROE	-52.55%
ROIC	N/A

ROA(3y)-18.22%

ROA(5y)-11.26%

ROE(3y)-38.51%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DNMR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DNMR does not have a ROIC to compare to the WACC, probably because it is not profitable.

DNMR has more shares outstanding than it did 1 year ago.

DNMR has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -1.42, we must say that DNMR is in the distress zone and has some risk of bankruptcy.

DNMR has a Altman-Z score of -1.42. This is amonst the worse of the industry: DNMR underperforms 84.34% of its industry peers.

A Debt/Equity ratio of 1.80 is on the high side and indicates that DNMR has dependencies on debt financing.

DNMR has a worse Debt to Equity ratio (1.80) than 84.34% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.8
Debt/FCF	N/A
Altman-Z	-1.42

ROIC/WACCN/A

WACC5.8%

2.3 Liquidity

DNMR has a Current Ratio of 3.28. This indicates that DNMR is financially healthy and has no problem in meeting its short term obligations.

DNMR has a Current ratio of 3.28. This is amongst the best in the industry. DNMR outperforms 86.75% of its industry peers.

DNMR has a Quick Ratio of 2.05. This indicates that DNMR is financially healthy and has no problem in meeting its short term obligations.

With a decent Quick ratio value of 2.05, DNMR is doing good in the industry, outperforming 79.52% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.28
Quick Ratio	2.05

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

DNMR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -825.53%.

The Revenue for DNMR has decreased by -26.71% in the past year. This is quite bad

Measured over the past years, DNMR shows a decrease in Revenue. The Revenue has been decreasing by -0.46% on average per year.

EPS 1Y (TTM)-825.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1130.77%

Revenue 1Y (TTM)-26.71%

Revenue growth 3Y-0.46%

Revenue growth 5YN/A

Sales Q2Q%-21.17%

3.2 Future

The Earnings Per Share is expected to grow by 18.49% on average over the next years. This is quite good.

Based on estimates for the next years, DNMR will show a very strong growth in Revenue. The Revenue will grow by 52.38% on average per year.

EPS Next Y-2050.95%

EPS Next 2Y-266.9%

EPS Next 3Y-108.23%

EPS Next 5Y18.49%

Revenue Next Year-21.44%

Revenue Next 2Y29.07%

Revenue Next 3Y53.32%

Revenue Next 5Y52.38%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DNMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DNMR. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

DNMR's earnings are expected to decrease with -108.23% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-266.9%

EPS Next 3Y-108.23%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DNMR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DANIMER SCIENTIFIC INC

NYSE:DNMR (12/18/2024, 11:50:00 AM)

3.5

-0.26 (-6.91%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap10.57M

Analysts

Price Target

Short Float %

Short Ratio

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-17.27%
ROE	-52.55%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.06

Health

		Industry Rank	Sector Rank
Debt/Equity	1.8
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	3.28
Quick Ratio	2.05
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-825.53%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y-2050.95%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-26.71%

Revenue growth 3Y-0.46%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

DANIMER SCIENTIFIC INC (DNMR)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens